Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,450,059
+$2,298,650 QoQ
Shares Held
464,034
+7.2% QoQ
Ownership
0.721%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. CGEM ranks #111 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,450,059 464,034
2026-03-31 $6,151,409 432,893
2025-12-31 $4,515,425 436,273
2025-09-30 $2,387,643 402,638
2025-06-30 $3,279,435 435,516
2025-03-31 $3,211,663 424,262
2024-12-31 $5,249,226 430,971
2024-09-30 $7,097,073 423,959
2024-06-30 $6,463,804 370,631
2024-03-31 $4,394,155 257,873
2023-12-31 $2,513,923 246,705
2023-09-30 $2,081,373 229,986
2023-06-30 $1,999,057 185,786
2023-03-31 $1,918,462 187,533
2022-12-31 $2,326,971 220,566
2022-09-30 $2,788,837 217,538
2022-06-30 $2,381,609 185,773
2022-03-31 $1,865,230 178,150
2021-12-31 $2,688,106 174,213
2021-09-30 $3,853,692 170,744
2021-06-30 $2,309,749 89,699
2021-03-31 $3,601,579 86,431